Insights

Always ahead. Always knowledgeable.

Publications

What’s moving the market

Deep-dive research and evidence-based frameworks to help you navigate complex pricing, policy, and reimbursement landscapes.

12 Aug 2026

3 Aug 2026

22 Jun 2026

2 Jun 2026

30 May 2026

28 May 2026

20 May 2026

20 May 2026

ADVI Consultant Insights

Leadership perspective on markets

Strategic foresight and executive analysis to help you anticipate shifts in policy, pricing, and market access.

ADVI Health Accelerates Insights with Monthly Medicare Data

ADVI Health now has access to 100% of Medicare Parts A, B, and D research files with monthly availability – …

August 12, 2026

Why Clinical Laboratories Should Consider Weighing In on CMS and CDC’s New CLIA Request for Information

An opportunity for laboratories to help shape the future of CLIA regulation On July 16, 2026, the Centers for Medicare …

July 27, 2026

RAND/UCLA Modified Delphi Panels

ADVI Health partners with pharmaceutical and biotech organizations to advance their evidence generation and market access strategies. We support complex research questions through primary research (e.g., …

Caitlin Sheetz, MPH
June 23, 2026

Precision Medicine

Test Ordering Simplification Will Not Be Optional in the Near Future: Why Labs Must Act Before May 26, 2028

The Centers for Medicare & Medicaid Services’ (CMS) Administrative Simplification: Adoption of Standards for Health Care Claims Attachments Transactions and …

May 11, 2026

Precision Medicine

The MolDX Technical Assessment: How to Move Your Test from “Not Successful” to Medicare Coverage Success

In the laboratory space, the MolDX Technical Assessment (TA) is often the moment where the gap between “a great test” …

April 9, 2026

Precision Medicine

CRUSH and Genetic and Molecular Laboratories: A Potential Shift in Medicare Oversight

Genetic, molecular, and reference laboratories are closely watching a new Medicare concept known as CRUSH- short for Comprehensive Regulations to …

March 17, 2026

Oncology/biologics Precision Medicine

March Is Colorectal Cancer Awareness Month: Why CMS’s Proposed NCD 210.3 Update Could Accelerate Patient‑Centered Screening Access

Colorectal cancer (CRC) screening saves lives, but only when patients are able to access care in a way that meets …

March 17, 2026

MFN shifts from noise to credible threat

Throughout 2025, MFN-like concepts were diffuse background noise. That volume intensified in Q4, when legislative and regulatory conversations crystallized around …

Marc Samuels, JD, MPH
March 16, 2026

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.